{"id":16662,"date":"2026-06-16T14:34:59","date_gmt":"2026-06-16T12:34:59","guid":{"rendered":"https:\/\/www.interpharma.ch\/?p=16662"},"modified":"2026-06-16T14:52:08","modified_gmt":"2026-06-16T12:52:08","slug":"communique-de-presse-enquete-sur-leurope-2026-toujours-un-large-soutien-aux-accords-bilateraux","status":"publish","type":"post","link":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-enquete-sur-leurope-2026-toujours-un-large-soutien-aux-accords-bilateraux\/","title":{"rendered":"Communiqu\u00e9 de presse: Enqu\u00eate sur l\u2019Europe 2026: toujours un large soutien aux accords bilat\u00e9raux"},"content":{"rendered":"\n

La population suisse continue d\u2019avoir une opinion largement positive et pragmatique des accords bilat\u00e9raux. Les avantages dominent nettement. Dans ce contexte, la 13e enqu\u00eate repr\u00e9sentative sur l\u2019Europe d\u2019Interparma r\u00e9alis\u00e9e par gfs.bern montre que si la votation sur le paquet Suisse-UE (Bilat\u00e9rales III) avait lieu aujourd\u2019hui, 62% des citoyen-ne-s voteraient pour, 31% contre. Les Bilat\u00e9rales III sont per\u00e7ues comme un prolongement de la voie bilat\u00e9rale \u00e9prouv\u00e9e et tirent profit de la stabilit\u00e9 de cette position de fond.<\/strong><\/p>\n\n\n\n

Les accords bilat\u00e9raux actuels restent largement soutenus. Pour une majorit\u00e9 des citoyen-ne-s, ce sont les avantages qui dominent nettement, bien que les avis sur les relations avec l\u2019UE soient globalement plus nuanc\u00e9s actuellement. De m\u00eame que les ann\u00e9es pr\u00e9c\u00e9dentes, les principaux arguments en faveur du paquet d\u2019accords sont l\u2019acc\u00e8s au march\u00e9 d\u2019exportation europ\u00e9en (84%) et le r\u00f4le des accords bilat\u00e9raux existants en tant que moteur de prosp\u00e9rit\u00e9 (74%).<\/p>\n\n\n\n

Une minorit\u00e9 appuie son rejet essentiellement sur la perception de l\u2019UE comme un mastodonte bureaucratique (78%) ainsi que sur les inqui\u00e9tudes li\u00e9es \u00e0 la pression sur les salaires (66%) et \u00e0 l\u2019immigration dans les assurances sociales (59%).<\/p>\n\n\n\n

Les incertitudes renforcent le souhait de relations stables avec l\u2019UE<\/h2>\n\n\n\n

Les incertitudes g\u00e9opolitiques modifient la perception que les citoyen-ne-s ont des relations avec l\u2019UE. Une claire majorit\u00e9 reconna\u00eet que la prosp\u00e9rit\u00e9 de la Suisse d\u00e9pend du bon fonctionnement des relations \u00e9conomiques internationales. De ce fait, le souhait de stabilit\u00e9 prend de l\u2019importance, en particulier s\u2019agissant de l\u2019acc\u00e8s assur\u00e9 au march\u00e9 et de conditions cadres juridiques fiables pour l\u2019\u00e9conomie.<\/p>\n\n\n\n

Ren\u00e9 Buholzer, directeur d\u2019Interpharma, d\u00e9clare:<\/strong> \u00abL\u2019UE est notre principale partenaire commerciale. En particulier dans un contexte g\u00e9opolitique de plus en plus concurrentiel et incertain, il est d\u00e9cisif pour la Suisse d\u2019avoir des conditions cadres pr\u00e9visibles pour pouvoir sauvegarder sa force dans l\u2019innovation, la recherche et la production. Il est encourageant de constater que la population suisse \u00e9met un signal clair en faveur de la voie bilat\u00e9rale. Les Bilat\u00e9rales III offrent une chance de d\u00e9velopper ces relations et d\u2019assurer leur avenir.\u00bb<\/em><\/p>\n\n\n\n

Sur les diff\u00e9rents sc\u00e9narios des futures relations avec l\u2019UE, le seul actuellement majoritaire est un renforcement des accords bilat\u00e9raux sous la forme d\u2019un ou plusieurs nouveaux accords, m\u00eame si cela implique la reprise du droit europ\u00e9en (53%). Seule une minorit\u00e9 se d\u00e9clare favorable \u00e0 un accord de libre-\u00e9change sans autres accords bilat\u00e9raux (43%), \u00e0 l\u2019adh\u00e9sion \u00e0 l\u2019EEE (47%) ou au maintien des accords bilat\u00e9raux actuels sans possibilit\u00e9 d\u2019adaptations (40%).<\/p>\n\n\n\n

Les Bilat\u00e9rales III b\u00e9n\u00e9ficient d\u2019une vision pragmatique de leurs avantages<\/h2>\n\n\n\n

Les intentions de vote clairement en faveur des Bilat\u00e9rales III sont surtout port\u00e9es par la perspective de pouvoir continuer \u00e0 les d\u00e9velopper. La possibilit\u00e9 de moderniser et renforcer les accords bilat\u00e9raux de mani\u00e8re cibl\u00e9e contribue particuli\u00e8rement \u00e0 l\u2019approbation.<\/p>\n\n\n\n

Urs Bieri, co-directeur et membre du conseil d\u2019administration de gfs.bern, explique:<\/strong> \u00abLa population suisse sait que sa prosp\u00e9rit\u00e9 d\u00e9pend des relations \u00e9conomiques avec d\u2019autres pays et tout particuli\u00e8rement de celles avec l\u2019UE. Ainsi, pr\u00e8s de deux tiers consid\u00e8rent le paquet Suisse-UE comme un renforcement de la voie suivie jusqu\u2019\u00e0 pr\u00e9sent et souhaitent la poursuivre \u00e0 l\u2019avenir.\u00bb<\/em><\/p>\n\n\n\n

Le projet est donc consid\u00e9r\u00e9 comme une poursuite logique du mod\u00e8le \u00e9prouv\u00e9 qui, du point de vue de la population, continue d\u2019apporter des avantages \u00e9conomiques clairs.<\/p>\n\n\n\n

Les personnes qui tendent vers le \u00abnon\u00bb sont surtout celles qui per\u00e7oivent la libre circulation des personnes comme avantageuse uniquement pour l\u2019UE ou qui pensent que la Suisse n\u2019a pas suffisamment son mot \u00e0 dire et que c\u2019est toujours la Cour de justice de l\u2019Union europ\u00e9enne qui tranche en dernier ressort. Mais seule une minorit\u00e9 partage ces inqui\u00e9tudes.<\/p>\n","protected":false},"excerpt":{"rendered":"

La population suisse continue d\u2019avoir une opinion largement positive et pragmatique des accords bilat\u00e9raux. Les avantages dominent nettement. Dans ce contexte, la 13e enqu\u00eate repr\u00e9sentative sur l\u2019Europe d\u2019Interparma r\u00e9alis\u00e9e par gfs.bern montre que si la votation sur le paquet Suisse-UE (Bilat\u00e9rales III) avait lieu aujourd\u2019hui, 62% des citoyen-ne-s voteraient pour, 31% contre. Les Bilat\u00e9rales III […]<\/p>\n","protected":false},"author":7,"featured_media":11190,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"tags":[136,145,148,178],"class_list":["post-16662","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","tag-europe","tag-les-bilaterales","tag-place-pharmaceutique-suisse","tag-medienmitteilung"],"acf":[],"yoast_head":"\nCommuniqu\u00e9 de presse: Enqu\u00eate sur l\u2019Europe 2026: toujours un large soutien aux accords bilat\u00e9raux - Interpharma<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-enquete-sur-leurope-2026-toujours-un-large-soutien-aux-accords-bilateraux\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Communiqu\u00e9 de presse: Enqu\u00eate sur l\u2019Europe 2026: toujours un large soutien aux accords bilat\u00e9raux\" \/>\n<meta property=\"og:description\" content=\"La population suisse continue d\u2019avoir une opinion largement positive et pragmatique des accords bilat\u00e9raux. Les avantages dominent nettement. Dans ce contexte, la 13e enqu\u00eate repr\u00e9sentative sur l\u2019Europe d\u2019Interparma r\u00e9alis\u00e9e par gfs.bern montre que si la votation sur le paquet Suisse-UE (Bilat\u00e9rales III) avait lieu aujourd\u2019hui, 62% des citoyen-ne-s voteraient pour, 31% contre. Les Bilat\u00e9rales III […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-enquete-sur-leurope-2026-toujours-un-large-soutien-aux-accords-bilateraux\/\" \/>\n<meta property=\"og:site_name\" content=\"Interpharma\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-16T12:34:59+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-16T12:52:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2025\/07\/CH_EU_generisch-klein-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1731\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"lukaskuemmerli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@interpharma_ch\" \/>\n<meta name=\"twitter:site\" content=\"@interpharma_ch\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"lukaskuemmerli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-enquete-sur-leurope-2026-toujours-un-large-soutien-aux-accords-bilateraux\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-enquete-sur-leurope-2026-toujours-un-large-soutien-aux-accords-bilateraux\/\"},\"author\":{\"name\":\"lukaskuemmerli\",\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/person\/2854d813965ba4a7feaeffbe96f8eadf\"},\"headline\":\"Communiqu\u00e9 de presse: Enqu\u00eate sur l\u2019Europe 2026: toujours un large soutien aux accords bilat\u00e9raux\",\"datePublished\":\"2026-06-16T12:34:59+00:00\",\"dateModified\":\"2026-06-16T12:52:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-enquete-sur-leurope-2026-toujours-un-large-soutien-aux-accords-bilateraux\/\"},\"wordCount\":687,\"publisher\":{\"@id\":\"https:\/\/www.interpharma.ch\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-enquete-sur-leurope-2026-toujours-un-large-soutien-aux-accords-bilateraux\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2025\/07\/CH_EU_generisch-klein-scaled.jpg\",\"keywords\":[\"Europe\",\"les bilat\u00e9rales\",\"place pharmaceutique suisse\",\"Communiqu\u00e9s de presse\"],\"inLanguage\":\"fr-FR\",\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\/\/www.interpharma.ch\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-enquete-sur-leurope-2026-toujours-un-large-soutien-aux-accords-bilateraux\/\",\"url\":\"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-enquete-sur-leurope-2026-toujours-un-large-soutien-aux-accords-bilateraux\/\",\"name\":\"Communiqu\u00e9 de presse: Enqu\u00eate sur l\u2019Europe 2026: toujours un large soutien aux accords bilat\u00e9raux - Interpharma\",\"isPartOf\":{\"@id\":\"https:\/\/www.interpharma.ch\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-enquete-sur-leurope-2026-toujours-un-large-soutien-aux-accords-bilateraux\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-enquete-sur-leurope-2026-toujours-un-large-soutien-aux-accords-bilateraux\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2025\/07\/CH_EU_generisch-klein-scaled.jpg\",\"datePublished\":\"2026-06-16T12:34:59+00:00\",\"dateModified\":\"2026-06-16T12:52:08+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-enquete-sur-leurope-2026-toujours-un-large-soutien-aux-accords-bilateraux\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-enquete-sur-leurope-2026-toujours-un-large-soutien-aux-accords-bilateraux\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-enquete-sur-leurope-2026-toujours-un-large-soutien-aux-accords-bilateraux\/#primaryimage\",\"url\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2025\/07\/CH_EU_generisch-klein-scaled.jpg\",\"contentUrl\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2025\/07\/CH_EU_generisch-klein-scaled.jpg\",\"width\":2560,\"height\":1731,\"caption\":\"Relation Suisse-UE\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-enquete-sur-leurope-2026-toujours-un-large-soutien-aux-accords-bilateraux\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\/\/www.interpharma.ch\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Communiqu\u00e9 de presse: Enqu\u00eate sur l\u2019Europe 2026: toujours un large soutien aux accords bilat\u00e9raux\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.interpharma.ch\/#website\",\"url\":\"https:\/\/www.interpharma.ch\/\",\"name\":\"Interpharma\",\"description\":\"Verband der forschenden Pharmazeutischen Firmen\",\"publisher\":{\"@id\":\"https:\/\/www.interpharma.ch\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.interpharma.ch\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.interpharma.ch\/#organization\",\"name\":\"Interpharma\",\"url\":\"https:\/\/www.interpharma.ch\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg\",\"contentUrl\":\"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg\",\"width\":\"1200\",\"height\":\"1200\",\"caption\":\"Interpharma\"},\"image\":{\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/interpharma_ch\",\"https:\/\/ch.linkedin.com\/company\/interpharma\",\"https:\/\/www.instagram.com\/interpharma_ch\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/person\/2854d813965ba4a7feaeffbe96f8eadf\",\"name\":\"lukaskuemmerli\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/c3bfeac2b6c479264ad184573779a451a81113f9e7cbabe607006461ca783d10?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/c3bfeac2b6c479264ad184573779a451a81113f9e7cbabe607006461ca783d10?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/c3bfeac2b6c479264ad184573779a451a81113f9e7cbabe607006461ca783d10?s=96&d=mm&r=g\",\"caption\":\"lukaskuemmerli\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Communiqu\u00e9 de presse: Enqu\u00eate sur l\u2019Europe 2026: toujours un large soutien aux accords bilat\u00e9raux - Interpharma","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-enquete-sur-leurope-2026-toujours-un-large-soutien-aux-accords-bilateraux\/","og_locale":"fr_FR","og_type":"article","og_title":"Communiqu\u00e9 de presse: Enqu\u00eate sur l\u2019Europe 2026: toujours un large soutien aux accords bilat\u00e9raux","og_description":"La population suisse continue d\u2019avoir une opinion largement positive et pragmatique des accords bilat\u00e9raux. Les avantages dominent nettement. Dans ce contexte, la 13e enqu\u00eate repr\u00e9sentative sur l\u2019Europe d\u2019Interparma r\u00e9alis\u00e9e par gfs.bern montre que si la votation sur le paquet Suisse-UE (Bilat\u00e9rales III) avait lieu aujourd\u2019hui, 62% des citoyen-ne-s voteraient pour, 31% contre. Les Bilat\u00e9rales III […]","og_url":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-enquete-sur-leurope-2026-toujours-un-large-soutien-aux-accords-bilateraux\/","og_site_name":"Interpharma","article_published_time":"2026-06-16T12:34:59+00:00","article_modified_time":"2026-06-16T12:52:08+00:00","og_image":[{"width":2560,"height":1731,"url":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2025\/07\/CH_EU_generisch-klein-scaled.jpg","type":"image\/jpeg"}],"author":"lukaskuemmerli","twitter_card":"summary_large_image","twitter_creator":"@interpharma_ch","twitter_site":"@interpharma_ch","twitter_misc":{"\u00c9crit par":"lukaskuemmerli","Dur\u00e9e de lecture estim\u00e9e":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-enquete-sur-leurope-2026-toujours-un-large-soutien-aux-accords-bilateraux\/#article","isPartOf":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-enquete-sur-leurope-2026-toujours-un-large-soutien-aux-accords-bilateraux\/"},"author":{"name":"lukaskuemmerli","@id":"https:\/\/www.interpharma.ch\/#\/schema\/person\/2854d813965ba4a7feaeffbe96f8eadf"},"headline":"Communiqu\u00e9 de presse: Enqu\u00eate sur l\u2019Europe 2026: toujours un large soutien aux accords bilat\u00e9raux","datePublished":"2026-06-16T12:34:59+00:00","dateModified":"2026-06-16T12:52:08+00:00","mainEntityOfPage":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-enquete-sur-leurope-2026-toujours-un-large-soutien-aux-accords-bilateraux\/"},"wordCount":687,"publisher":{"@id":"https:\/\/www.interpharma.ch\/#organization"},"image":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-enquete-sur-leurope-2026-toujours-un-large-soutien-aux-accords-bilateraux\/#primaryimage"},"thumbnailUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2025\/07\/CH_EU_generisch-klein-scaled.jpg","keywords":["Europe","les bilat\u00e9rales","place pharmaceutique suisse","Communiqu\u00e9s de presse"],"inLanguage":"fr-FR","copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/www.interpharma.ch\/#organization"}},{"@type":"WebPage","@id":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-enquete-sur-leurope-2026-toujours-un-large-soutien-aux-accords-bilateraux\/","url":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-enquete-sur-leurope-2026-toujours-un-large-soutien-aux-accords-bilateraux\/","name":"Communiqu\u00e9 de presse: Enqu\u00eate sur l\u2019Europe 2026: toujours un large soutien aux accords bilat\u00e9raux - Interpharma","isPartOf":{"@id":"https:\/\/www.interpharma.ch\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-enquete-sur-leurope-2026-toujours-un-large-soutien-aux-accords-bilateraux\/#primaryimage"},"image":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-enquete-sur-leurope-2026-toujours-un-large-soutien-aux-accords-bilateraux\/#primaryimage"},"thumbnailUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2025\/07\/CH_EU_generisch-klein-scaled.jpg","datePublished":"2026-06-16T12:34:59+00:00","dateModified":"2026-06-16T12:52:08+00:00","breadcrumb":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-enquete-sur-leurope-2026-toujours-un-large-soutien-aux-accords-bilateraux\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-enquete-sur-leurope-2026-toujours-un-large-soutien-aux-accords-bilateraux\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-enquete-sur-leurope-2026-toujours-un-large-soutien-aux-accords-bilateraux\/#primaryimage","url":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2025\/07\/CH_EU_generisch-klein-scaled.jpg","contentUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2025\/07\/CH_EU_generisch-klein-scaled.jpg","width":2560,"height":1731,"caption":"Relation Suisse-UE"},{"@type":"BreadcrumbList","@id":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-enquete-sur-leurope-2026-toujours-un-large-soutien-aux-accords-bilateraux\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/www.interpharma.ch\/fr\/"},{"@type":"ListItem","position":2,"name":"Communiqu\u00e9 de presse: Enqu\u00eate sur l\u2019Europe 2026: toujours un large soutien aux accords bilat\u00e9raux"}]},{"@type":"WebSite","@id":"https:\/\/www.interpharma.ch\/#website","url":"https:\/\/www.interpharma.ch\/","name":"Interpharma","description":"Verband der forschenden Pharmazeutischen Firmen","publisher":{"@id":"https:\/\/www.interpharma.ch\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.interpharma.ch\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.interpharma.ch\/#organization","name":"Interpharma","url":"https:\/\/www.interpharma.ch\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/","url":"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg","contentUrl":"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg","width":"1200","height":"1200","caption":"Interpharma"},"image":{"@id":"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/interpharma_ch","https:\/\/ch.linkedin.com\/company\/interpharma","https:\/\/www.instagram.com\/interpharma_ch\/"]},{"@type":"Person","@id":"https:\/\/www.interpharma.ch\/#\/schema\/person\/2854d813965ba4a7feaeffbe96f8eadf","name":"lukaskuemmerli","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/c3bfeac2b6c479264ad184573779a451a81113f9e7cbabe607006461ca783d10?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/c3bfeac2b6c479264ad184573779a451a81113f9e7cbabe607006461ca783d10?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/c3bfeac2b6c479264ad184573779a451a81113f9e7cbabe607006461ca783d10?s=96&d=mm&r=g","caption":"lukaskuemmerli"}}]}},"_links":{"self":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts\/16662","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/comments?post=16662"}],"version-history":[{"count":4,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts\/16662\/revisions"}],"predecessor-version":[{"id":16683,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts\/16662\/revisions\/16683"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/media\/11190"}],"wp:attachment":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/media?parent=16662"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/tags?post=16662"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}